Investor Presentaiton

Financial snapshot ASX: TLX Share price (12 months to 19 January 2022) AUD Market information (as of 19 January 2022) Share price Market capitalisation Shares on issue Options on issue $8.09 9.00 ~$2.45B 8.00 285M ~18M 7.00 Cash balance as of 31 December 2021 $22M 6.00 For personal use only Top 5 shareholders (as of 5 January 2022) 5.00 Dr. Christian Behrenbruch (CEO & co-founder) 8.7% Dr. Andreas Kluge (co-founder) 8.7% 4.00 China Grand Pharma Fidelity (FIL) 7.3% 5.7% 3.00 UV-CAP GMBH & CO KG 2.7% Mar 2021 May 2021 Telix Pharmaceuticals Limited (ASX: TLX) Чари кл Jul 2021 Sept 2021 Nov 2021 Jan 2022 LO 5 TELIX PHARMACEUTICALS

View entire presentation